JP2014525448A5 - - Google Patents

Download PDF

Info

Publication number
JP2014525448A5
JP2014525448A5 JP2014528537A JP2014528537A JP2014525448A5 JP 2014525448 A5 JP2014525448 A5 JP 2014525448A5 JP 2014528537 A JP2014528537 A JP 2014528537A JP 2014528537 A JP2014528537 A JP 2014528537A JP 2014525448 A5 JP2014525448 A5 JP 2014525448A5
Authority
JP
Japan
Prior art keywords
imidazo
oxadiazol
pyridine
methyl
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014528537A
Other languages
English (en)
Japanese (ja)
Other versions
JP6134319B2 (ja
JP2014525448A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/052802 external-priority patent/WO2013033167A1/en
Publication of JP2014525448A publication Critical patent/JP2014525448A/ja
Publication of JP2014525448A5 publication Critical patent/JP2014525448A5/ja
Application granted granted Critical
Publication of JP6134319B2 publication Critical patent/JP6134319B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014528537A 2011-09-01 2012-08-29 c−kitキナーゼインヒビターとしての化合物及び組成物 Active JP6134319B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161530038P 2011-09-01 2011-09-01
US61/530,038 2011-09-01
PCT/US2012/052802 WO2013033167A1 (en) 2011-09-01 2012-08-29 Compounds and compositions as c-kit kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2014525448A JP2014525448A (ja) 2014-09-29
JP2014525448A5 true JP2014525448A5 (OSRAM) 2015-10-29
JP6134319B2 JP6134319B2 (ja) 2017-05-24

Family

ID=46829904

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014528537A Active JP6134319B2 (ja) 2011-09-01 2012-08-29 c−kitキナーゼインヒビターとしての化合物及び組成物

Country Status (30)

Country Link
US (3) US8569283B2 (OSRAM)
EP (1) EP2751104B1 (OSRAM)
JP (1) JP6134319B2 (OSRAM)
KR (1) KR101962495B1 (OSRAM)
CN (1) CN103797011B (OSRAM)
AP (1) AP2014007493A0 (OSRAM)
AR (1) AR087753A1 (OSRAM)
AU (1) AU2012302042B2 (OSRAM)
BR (1) BR112014004560A2 (OSRAM)
CA (1) CA2845169C (OSRAM)
CL (1) CL2014000492A1 (OSRAM)
CO (1) CO6900141A2 (OSRAM)
CR (1) CR20140107A (OSRAM)
CU (1) CU20140024A7 (OSRAM)
EA (1) EA026152B1 (OSRAM)
ES (1) ES2761332T3 (OSRAM)
GT (1) GT201400034A (OSRAM)
IL (1) IL231227A0 (OSRAM)
MA (1) MA35460B1 (OSRAM)
MX (1) MX339937B (OSRAM)
PE (1) PE20140909A1 (OSRAM)
PH (1) PH12014500372A1 (OSRAM)
PL (1) PL2751104T3 (OSRAM)
PT (1) PT2751104T (OSRAM)
SG (1) SG2014014369A (OSRAM)
TN (1) TN2014000068A1 (OSRAM)
TW (1) TW201313717A (OSRAM)
UY (1) UY34301A (OSRAM)
WO (1) WO2013033167A1 (OSRAM)
ZA (1) ZA201401175B (OSRAM)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9199981B2 (en) * 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
BR112014004560A2 (pt) 2011-09-01 2017-04-04 Irm Llc compostos e composições como inibidores de c-kit quinase
CN109568319A (zh) 2013-01-10 2019-04-05 普尔莫凯恩股份有限公司 非选择性激酶抑制剂
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
JP6483714B2 (ja) 2013-10-11 2019-03-13 ローレンス エス. ジスマン, 噴霧乾燥製剤
US20150288928A1 (en) * 2014-04-08 2015-10-08 Sony Corporation Security camera system use of object location tracking data
CN105384738B (zh) * 2014-08-21 2017-08-29 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
UY36294A (es) 2014-09-12 2016-04-29 Novartis Ag Compuestos y composiciones como inhibidores de quinasa
AU2016287478B2 (en) 2015-07-02 2021-10-21 Janssen Sciences Ireland Uc Antibacterial compounds
US10474987B2 (en) * 2015-08-05 2019-11-12 Whirlpool Corporation Object recognition system for an appliance and method for managing household inventory of consumables
WO2017214413A1 (en) * 2016-06-08 2017-12-14 Chrysalis, Inc. Imidazo[1,2-a]pyridine derivatives as histone demethylase inhibitors
JP2019518046A (ja) 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
EA201990044A1 (ru) 2016-06-16 2019-05-31 Янссен Сайенсиз Айрлэнд Анлимитед Компани Гетероциклические соединения в качестве антибактериальных средств
KR102341660B1 (ko) 2016-09-19 2021-12-23 노파르티스 아게 Raf 억제제 및 erk 억제제를 포함하는 치료적 조합
JP2020500183A (ja) 2016-10-27 2020-01-09 プルモキネ、インコーポレイテッド 肺高血圧症の治療のための併用療法
US20180162291A1 (en) * 2016-12-12 2018-06-14 Wipro Limited System and method of dynamically adjusting field of view of an image capturing device
US11224596B2 (en) 2017-03-01 2022-01-18 Janssen Sciences Ireland Unlimited Company PZA and cytochrome bc1 inhibitor combination treatment
CN110494166B (zh) 2017-05-02 2022-11-08 诺华股份有限公司 组合疗法
EP3704115A1 (en) 2017-11-02 2020-09-09 Calico Life Sciences LLC Modulators of the integrated stress pathway
KR102625224B1 (ko) * 2018-10-31 2024-01-15 주식회사 큐로젠 피라졸-온 유도체를 유효성분으로 포함하는 자가면역질환의 예방, 개선 또는 치료용 조성물
KR20210142154A (ko) 2019-03-21 2021-11-24 옹쎄오 암 치료를 위한 키나제 억제제와 조합된 dbait 분자
BR112021022335A2 (pt) 2019-05-13 2021-12-28 Novartis Ag Formas cristalinas de n-(3-(2-(2-hidroxietoxi)-6-morfolinopiridin-4-il)-4-metilfenil)-2 (trifluorome-til)isonicotinamida como inibidores raf para o tratamento de câncer
MX2021013814A (es) * 2019-05-13 2022-02-10 Novartis Ag Formas cristalinas de n-(5-(5-((1r,2s)-2-fluorociclopropil)-1,2,4- oxadiazol-3-yl)-2- metilfenil)imidazo[1,2-a]piridin-3-carboxamida.
WO2021035788A1 (zh) 2019-08-29 2021-03-04 中国科学院合肥物质科学研究院 吡唑衍生物及其用途
US20220340564A1 (en) 2019-09-13 2022-10-27 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
CN114761006A (zh) 2019-11-08 2022-07-15 Inserm(法国国家健康医学研究院) 对激酶抑制剂产生耐药性的癌症的治疗方法
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
JP2023534963A (ja) 2020-07-15 2023-08-15 サード ハーモニック バイオ, インコーポレイテッド 選択的c-kitキナーゼ阻害剤の結晶質形態
JP2023551434A (ja) 2020-11-19 2023-12-08 サード ハーモニック バイオ, インコーポレイテッド 選択的c-kitキナーゼ阻害剤の医薬組成物ならびにその作製および使用のための方法
KR20230157400A (ko) 2021-03-16 2023-11-16 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 항박테리아성 화합물
AU2022240967A1 (en) 2021-03-17 2023-11-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
KR20230157445A (ko) 2021-03-17 2023-11-16 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 항박테리아성 화합물
US20250034171A1 (en) 2021-10-28 2025-01-30 Janssen Sciences Ireland Unlimited Company Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
JP2025540958A (ja) 2022-11-30 2025-12-17 ブループリント メディシンズ コーポレイション 蕁麻疹の治療のための野生型c-kitキナーゼ阻害剤としてのN-フェニル-ピラゾロ[1,5-A]ピリジン-3-カルボキサミド誘導体
CN120677155A (zh) * 2022-12-07 2025-09-19 第三谐波生物股份有限公司 作为c-Kit激酶抑制剂的化合物和组合物
CN120659784A (zh) * 2022-12-07 2025-09-16 第三谐波生物股份有限公司 作为c-Kit激酶抑制剂的化合物和组合物
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
WO2025072330A1 (en) * 2023-09-26 2025-04-03 Arcus Biosciences, Inc. Kit inhibitor compounds and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003251561A1 (en) 2002-06-20 2004-01-06 Beacon Looms, Inc. Knitted electrical conductor fabric
JP2007524596A (ja) 2003-02-28 2007-08-30 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 共結晶医薬組成物
EA013328B1 (ru) 2004-09-09 2010-04-30 Натко Фарма Лимитед Производные фениламинопиримидина как ингибиторы bcr-abl
WO2006071940A2 (en) 2004-12-23 2006-07-06 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
US7754717B2 (en) * 2005-08-15 2010-07-13 Amgen Inc. Bis-aryl amide compounds and methods of use
RU2009120882A (ru) * 2006-11-03 2010-12-10 Айрм Ллк (Bm) Соединения и композиции, как ингибиторы протеинкиназы
AU2011329233A1 (en) * 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
US20130023751A1 (en) 2011-07-18 2013-01-24 Samuel Victor Lichtenstein Water retention monitoring
WO2013033203A1 (en) 2011-09-01 2013-03-07 Irm Llc Compounds and compositions as c-kit kinase inhibitors
BR112014004560A2 (pt) 2011-09-01 2017-04-04 Irm Llc compostos e composições como inibidores de c-kit quinase
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
WO2013033620A1 (en) 2011-09-01 2013-03-07 Irm Llc Compounds and compositions as pdgfr kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2014525448A5 (OSRAM)
ES2727376T3 (es) Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK
JP2019530667A (ja) ピリジル置換のインドール化合物
CN113544130A (zh) 一种btk抑制剂环衍生物及其制备方法和药学上的应用
JP2019530667A5 (OSRAM)
JP2015522002A5 (OSRAM)
KR20130038420A (ko) 브루톤 티로신 키나아제의 억제제
AU2008267894A1 (en) Isoxazole-imidazole derivatives
RU2015144485A (ru) Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ
WO2022165530A1 (en) Small molecule inhibitors of salt inducible kinases
TW202233598A (zh) PPARγ調節劑及使用方法
EP4504719A1 (en) Egfr inhibitors
EP3807269A1 (en) New isoxazolyl ether derivatives as gaba a alpha5 pam
WO2021228795A1 (en) New triazolyl derivatives as gaba a alpha5 pam
RU2800160C2 (ru) Новые производные простого эфира изоксазолила в качестве пам гамк a альфа5
JP2023523300A (ja) Ccr6受容体調節剤としてのアゼチジン-3-イルメタノール誘導体
EA049700B1 (ru) Производные азетидин-3-илметанола в качестве модуляторов рецептора ccr6
HK1233645A1 (en) Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds